Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PMV is a dry powder formulation of the live attenuated measles vaccine, specifically utilizing the Edmonston-Zagreb strain, developed by the Serum Institute of India. Unlike traditional measles vaccines administered via subcutaneous injection, PMV is designed for needle-free delivery through inhalation using specialized devices such as the Puffhaler or Solovent. This formulation aims to enhance the thermostability of the vaccine, potentially eliminating the need for a strict cold chain, and to simplify mass immunization efforts by providing a non-invasive administration route that can induce both systemic and mucosal immunity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Dry Powder Measles Vaccine (Serum Institute of India).